Welcome to LookChem.com Sign In|Join Free

CAS

  • or

452-06-2

Post Buying Request

452-06-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

452-06-2 Usage

Chemical Properties

white to light yellow crystal powder

Uses

Different sources of media describe the Uses of 452-06-2 differently. You can refer to the following data:
1. A probe of structural dynamics and charge transfer in DNA .
2. 2-Aminopurine has been used to inhibit eukaryotic initiation factor-2α (eIF2α)-phosphorylation of osteoarthritis (OA) chondrocytes.
3. A probe of structural dynamicas and charge transfer in DNA

Definition

ChEBI: The parent compound of the 2-aminopurines, comprising a purine core carrying an amino substituent at the 2-position.

Biochem/physiol Actions

2-Aminopurine (2AP) is an analog of guanosine and adenosine, which can base pair with cytosine and thymine. It is used as a fluorescent probe in nucleic acid structure and dynamics. 2-Aminopurine (2-AP) inhibits double-stranded RNA-dependent protein kinase, protein kinase R (PKR).

Safety Profile

Mutation data reported. Whenheated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 452-06-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,5 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 452-06:
(5*4)+(4*5)+(3*2)+(2*0)+(1*6)=52
52 % 10 = 2
So 452-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N5/c6-5-7-1-3-4(10-5)9-2-8-3/h1-3H,(H2,6,8,9,10)

452-06-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1111)  2-Aminopurine  >98.0%(HPLC)(T)

  • 452-06-2

  • 200mg

  • 1,290.00CNY

  • Detail
  • TCI America

  • (A1111)  2-Aminopurine  >98.0%(HPLC)(T)

  • 452-06-2

  • 1g

  • 4,730.00CNY

  • Detail
  • USP

  • (1269130)  FamciclovirRelatedCompoundE  United States Pharmacopeia (USP) Reference Standard

  • 452-06-2

  • 1269130-25MG

  • 13,501.80CNY

  • Detail

452-06-2Synthetic route

2-(methylthio)-9H-purine
33512-51-5

2-(methylthio)-9H-purine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With potassium amide In ammonia for 70h; Mechanism; 2-halogenated purines;90%
2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
In hydrogenchloride at 50℃; electrolysis, -0.75V, initial current 50-60 mA;85%
palladium on charcoal In sodium hydroxide; water
1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With methylamine In methanol at 100℃; for 17h;80%
1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

A

purine
120-73-0

purine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With ammonia In methanol at 100℃; for 17h; Mechanism; Product distribution;A 70%
B 20%
pyrimidine-2,4,5-triamine
3546-50-7

pyrimidine-2,4,5-triamine

dimethoxymethyl acetate
14036-53-4

dimethoxymethyl acetate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
1.) RT, 6 h, 2.) reflux, 30 min;61%
1-amino-2-(methylthio)purinium mesitylenesulfonate

1-amino-2-(methylthio)purinium mesitylenesulfonate

A

2-(methylthio)-9H-purine
33512-51-5

2-(methylthio)-9H-purine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With ammonia In methanol at 100℃; for 17h; Product distribution; Mechanism; ANRORC and no ANRORC mechanism determined by reaction with 15N labelled ammonia; var. temp. and time;A 55%
B 25%
amipurimycin
61991-08-0

amipurimycin

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With trifluoroacetic acid at 130℃;48%
6-(2-acetylvinylthio)-2-aminopurine

6-(2-acetylvinylthio)-2-aminopurine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With nickel In water for 7.5h; Heating;35.7%
iso-2',3'-dideoxyadenosine
107550-74-3

iso-2',3'-dideoxyadenosine

A

2,3-Didesoxy-β-D-glycero-pentofuranose
122999-44-4

2,3-Didesoxy-β-D-glycero-pentofuranose

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With hydrogenchloride at 22℃; rate of hydrolysis relative to dideoxyadenosine;
2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine
3616-24-8

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine

A

2,4-diamino-5-formamidopyrimidine
18620-60-5

2,4-diamino-5-formamidopyrimidine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With sodium cacodylate buffer; water at 110℃; for 22h; Kinetics; Thermodynamic data; Mechanism; ΔH(excit.); var. temp. and times;
thioguanine
154-42-7

thioguanine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / NaOH / dioxane; H2O / 5 - 10 °C
2: 35.7 percent / Raney nickel / H2O / 7.5 h / Heating
View Scheme
Conditions
ConditionsYield
With Canyon Diablo iron meteorites at 140℃; for 24h; Reagent/catalyst; Temperature;
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-aminopurine thallium salt

2-aminopurine thallium salt

Conditions
ConditionsYield
With thallium (I) ethoxide In ethanol at 15 - 20℃; for 36h;92%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2'-deoxy-2'-fluorouridine
56287-17-3, 69123-94-0, 784-71-4

2'-deoxy-2'-fluorouridine

2-amino-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purine

2-amino-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purine

Conditions
ConditionsYield
In water at 37℃; for 48h; thymidine phosphorylase, purine nucleoside phosphorylase, phosphate buffer, pH 7;89%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2'-Deoxycytidine
951-77-9

2'-Deoxycytidine

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine
3616-24-8

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine

Conditions
ConditionsYield
With citrate buffer; N-deoxyribosyltransferase from L. leichmannii In ethanol at 40℃; for 48h;86%
tert-butyl 4-bromobutyrate
110661-91-1

tert-butyl 4-bromobutyrate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

C13H19N5O2
1043904-91-1

C13H19N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50 - 80℃;85%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol
157363-84-3

1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol

1-(2-amino-9H-purin-9-yl)-2,5-anhydro-3,4-di-O-benzyl-1-deoxy-D-glucitol

1-(2-amino-9H-purin-9-yl)-2,5-anhydro-3,4-di-O-benzyl-1-deoxy-D-glucitol

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 2h;
Stage #2: 1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol In N,N-dimethyl-formamide at 110℃;
66%
sodium phenyl-methanolate
20194-18-7

sodium phenyl-methanolate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

N-(phenylmethyl)-aminopurine

N-(phenylmethyl)-aminopurine

Conditions
ConditionsYield
at 130℃; for 17h;63%
mesitylenesulfonylhydroxylamine
36016-40-7

mesitylenesulfonylhydroxylamine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

Conditions
ConditionsYield
In methanol; dichloromethane for 4h; Ambient temperature;62%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-amino-9-(β-D-arabinofuranosyl)purine

2-amino-9-(β-D-arabinofuranosyl)purine

Conditions
ConditionsYield
With phosphate buffer; cell paste of Enterobacter aerogenes AJ 11125 at 60℃; for 15h; pH 7.0;61%
4-acetoxy-3-(acetoxymethyl)-1-iodobutane
127047-77-2

4-acetoxy-3-(acetoxymethyl)-1-iodobutane

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

7-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
131266-15-4

7-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

B

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 18h; Ambient temperature;A 15%
B 59%
tert-butyl prop-2-ynoate
13831-03-3

tert-butyl prop-2-ynoate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

C12H15N5O2
1043904-89-7

C12H15N5O2

B

C12H15N5O2
1043904-90-0

C12H15N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50 - 80℃;A 57%
B 23%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

cis/trans-1-acetoxymethyl-2-bromo-2-(bromomethyl)cyclopropane

cis/trans-1-acetoxymethyl-2-bromo-2-(bromomethyl)cyclopropane

A

(Z,E)-2-amino-7-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

(Z,E)-2-amino-7-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

B

(Z,E)-2-amino-9-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

(Z,E)-2-amino-9-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20 - 65℃; for 8h;A 20%
B 53%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-(2-amino-9H-purin-9-yl)acetic acid
933477-63-5

2-(2-amino-9H-purin-9-yl)acetic acid

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Inert atmosphere;
Stage #2: ethyl bromoacetate In N,N-dimethyl-formamide for 2h; Inert atmosphere;
Stage #3: With sodium hydroxide In water; N,N-dimethyl-formamide at 20℃; for 1h; Inert atmosphere;
51%
(5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran
1134003-26-1

(5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran

9H-purin-2-amine
452-06-2

9H-purin-2-amine

(5aS,7S)-7-[(1R/S)-2-(2-amino-9H-purin-9-yl)-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran
1134003-03-4

(5aS,7S)-7-[(1R/S)-2-(2-amino-9H-purin-9-yl)-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With caesium carbonate In N,N-dimethyl-formamide at 25℃; for 1h; Inert atmosphere;
Stage #2: (5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran In N,N-dimethyl-formamide at 25℃; for 24h; Inert atmosphere;
48%
5-chloromethyl-2,2-dimethyl-1,3-dioxolane
4362-40-7

5-chloromethyl-2,2-dimethyl-1,3-dioxolane

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

9-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine
120139-11-9

9-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine

B

7-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine
120139-12-0

7-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 100℃; for 14h;A 44%
B 15%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2',3'-Dideoxyuridine
5983-09-5

2',3'-Dideoxyuridine

iso-2',3'-dideoxyadenosine
107550-74-3

iso-2',3'-dideoxyadenosine

Conditions
ConditionsYield
at 50℃; for 2h; Escherichia coli JA-300 cells, pH 6.5;44%
Diethyl 2-Bromoethoxymethanephosphonate
116384-57-7

Diethyl 2-Bromoethoxymethanephosphonate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

[2-(2-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid diethyl ester
126354-35-6

[2-(2-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid diethyl ester

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide a) At 80 deg C for 1 h 2) addition of IIc,80 deg C for 16 h;40%
diethyl-2-(2-bromoethylidene)malonte
51385-79-6

diethyl-2-(2-bromoethylidene)malonte

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-amino-9-(2,2-dicarboethoxycyclopropyl)purine
134470-59-0

2-amino-9-(2,2-dicarboethoxycyclopropyl)purine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide39%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

5-(chloromethyl)-1,2,3-trimethoxybenzene
3840-30-0

5-(chloromethyl)-1,2,3-trimethoxybenzene

9-(3,4,5-trimethoxybenzyl)-9H-purin-2-ylamine

9-(3,4,5-trimethoxybenzyl)-9H-purin-2-ylamine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 4h;36%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-deoxy-2-fluoro-α-D-arabinofuranose 1-phosphate
850883-62-4

2-deoxy-2-fluoro-α-D-arabinofuranose 1-phosphate

2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine

2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine

Conditions
ConditionsYield
purine nucleoside phosphorylase In water at 50℃; for 216h; pH=7.5; Aqueous phosphate buffer; Enzymatic reaction;32%
acetic anhydride
108-24-7

acetic anhydride

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-(N-acetylamino)purine
23567-61-5

2-(N-acetylamino)purine

Conditions
ConditionsYield
With ethanol 1) EtOH, 25 min, reflux, 2) 15 min, reflux; Yield given. Multistep reaction;

452-06-2Relevant articles and documents

Structure of amipurimycin, a nucleoside antibiotic having a novel branched sugar moiety

Goto,Toya,Ohgi,Kondo

, p. 1271 - 1274 (1982)

-

Synthesis and degradation of nucleic acid components by formamide and iron sulfur minerals

Saladino, Raffaele,Neri, Veronica,Crestini, Claudia,Costanzo, Giovanna,Graciotti, Michele,Di Mauro, Ernesto

experimental part, p. 15512 - 15518 (2009/03/12)

We describe the one-pot synthesis of a large panel of nucleic bases and related compounds from formamide in the presence of iron sulfur and iron-copper sulfur minerals as catalysts. The major products observed are purine, 1H-pyrimidinone, isocytosine, adenine, 2-aminopurine, carbodiimide, urea, and oxalic acid. Isocytosine and 2-aminopurine may recognize natural nucleobases by Watson-Crick and reverse Watson-Crick interactions, thus suggesting novel scenarios for the origin of primordial nucleic acids. Since the major problem in the origin of informational polymers is the instability of their precursors, we also investigate the effects of iron sulfur and iron-copper sulfur minerals on the stability of ribooligonucleotides in formamide and in water. All of the iron sulfur and iron-copper sulfur minerals stimulated degradation of RNA. The relevance of these findings with respect to the origin of informational polymers is discussed.

4'-substituted nucleosides

-

, (2008/06/13)

Nucleosides compounds of Formula I: STR1 wherein B is a purine or a pyrimidine; X and X' are H; Y is H; Y' is OH, F or H; or Y' and X' together makes a bond; Z is STR2 where n is zero, one, two or three; or Y' and Z together form a cyclic phosphate ester; Z' is --CN, --CH3, CH2 N3 or --CH2 J, where J is a halogen atom; or Z' and Y' together are --CH2 O--; and pharmaceutically acceptable esters, ethers, amides, N-acyl moieties and salts thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 452-06-2